The effect peer support in the diabetes control

Study effect of the peer support on glycosylated hemoglobin level in type II diabetic patients.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2013041012974N1

Enrollment

Registered

2013-08-20

Start date

2013-06-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes. Diabetes mellitus

Interventions

Intervention 1: After preparing peers, the participants in the intervention group in the selected center are supported by their peers in face to face meetings for 3 following months (10 sessions of 2

Prevention

After preparing peers, the participants in the intervention group in the selected center are supported by their peers in face to face meetings for 3 following months (10 sessions of 2 hours)whit Instr

the control group receive only routine care (such as the periodical doctor visits and pedagogical classes).

Eligibility

Sex/Gender

All

Age

30 Years to 75 Years

Inclusion criteria

Inclusion criteria: The major eligibility criteria: They include the age (above 30); a primary literacy; the lack of physical limitations for self-care. Before entering the study; their hemoglobin A1C should be higher than normal; with a medical profile in the diabetes clinic; having a history of diabetes type 2 at least for one year; having sufficient time to participle in the group sessions.The major outcome criteria: The Lack of mental health and physical health relating to the age that may hinder the learning; such as memory problems; Alzheimer's; etc. the use of the medicines that affect the consciousness and learning levels. The affection to other known chronic diseases such as kidney; autoimmunization diseases etc. Based on the patients’ own statements; medical and paramedical educations; the intention of immigration during the study and the background of similar study participation.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Hemoglobin glycoside. Timepoint: Before the intervention, three months after the intervention. Method of measurement: Based on percent with get blood samples.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRashidi Kobra

Lorestan University of Medical Sciences (School of Nursing Boroujerd

krashidi2010@yahoo.com+98 66 2446 7452

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026